Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 4/20 | 0.34 |
| ▸ | KMT2A known ✓ | Q03164 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL9603065 | 1.00 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2AL3MBTL1RAD52 | |
| Fumaric Acid SCHEMBL9602434 | 0.86 | KMT2A (0.42) | ALDH1A1MEN1KMT2AL3MBTL1RAD52 | |
| Fumaric Acid SCHEMBL9602442 | 0.86 | KMT2A (0.42) | ALDH1A1MEN1KMT2AL3MBTL1RAD52 | |
| Fumaric Acid SCHEMBL9867764 | 0.84 | L3MBTL1 (0.40) | ALDH1A1MEN1KMT2AL3MBTL1RAD52 | |
| SCHEMBL9602794 | 0.83 | CHRM2 (0.32) | MEN1KMT2AMAPTLMNANPC1 | |
| SCHEMBL9603113 | 0.80 | MAPT (0.37) | ALDH1A1MEN1KMT2AMAPTTDP1 | |
| Fumaric Acid SCHEMBL9866359 | 0.79 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1POLBLMNA | |
| Maleic Acid SCHEMBL9866351 | 0.79 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1POLBLMNA | |
| SCHEMBL9601582 | 0.79 | MAPK14 (0.40) | ALDH1A1MEN1KMT2AMAPTGAA | |
| Fumaric Acid SCHEMBL9602985 | 0.78 | MAPT (0.33) | ALDH1A1MEN1KMT2AL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0351435-B1 | FUSED PYRIDAZINE COMPOUNDS AND THEIR MEDICINAL USES | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1993-08-04 | — | — | EP | disclosed |